Profile data is unavailable for this security.
About the company
StemRIM Inc. is a Japan-based company mainly engaged in the regenerative medicine business. The Company is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.
- Revenue in JPY (TTM)0.00
- Net income in JPY-1.90bn
- Incorporated2006
- Employees45.00
- LocationStemRIM Inc3F, Saito Bio-Incubator, 7-7-15, SaitoIBARAKI-SHI 567-0085JapanJPN
- Phone+81 726487152
- Websitehttps://stemrim.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellSeed Inc | 120.30m | -1.03bn | 11.16bn | 38.00 | -- | 7.98 | -- | 92.80 | -29.71 | -29.71 | 3.47 | 37.83 | 0.0562 | 1.22 | 4.75 | 3,165,816.00 | -48.11 | -45.50 | -51.99 | -49.29 | 52.72 | 57.47 | -856.11 | -478.14 | 7.05 | -- | 0.0949 | -- | 1.65 | -6.87 | -1.57 | -- | 6.39 | -- |
| Wakamoto Pharmaceutical Co Ltd | 9.29bn | 298.60m | 11.29bn | 286.00 | 37.66 | 0.93 | 15.24 | 1.21 | 8.60 | 8.60 | 267.77 | 348.39 | 0.6006 | 1.62 | 3.06 | 32,493,160.00 | 1.93 | -0.0678 | 2.22 | -0.0781 | 47.70 | 48.65 | 3.21 | -0.1246 | 2.42 | -- | 0.0082 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
| Stella Pharma Corp | 991.86m | -180.01m | 12.39bn | 43.00 | -- | 4.27 | -- | 12.49 | -5.29 | -5.29 | 29.15 | 85.22 | 0.1958 | 0.1084 | 2.67 | 23,066,440.00 | -3.55 | -16.41 | -3.74 | -18.19 | 87.15 | 87.03 | -18.15 | -176.16 | 12.27 | -26.44 | 0.1917 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| ReproCell Inc | 2.52bn | -324.61m | 15.26bn | 99.00 | -- | 1.73 | -- | 6.06 | -3.42 | -3.42 | 26.63 | 92.82 | 0.2328 | 4.15 | 5.92 | 25,450,770.00 | -3.00 | -4.09 | -3.63 | -4.47 | 49.35 | 43.75 | -12.88 | -13.66 | 4.93 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 5.94bn | 853.00m | 15.29bn | 214.00 | 17.78 | 1.84 | 13.75 | 2.57 | 16.99 | 16.99 | 118.31 | 163.90 | 0.475 | 1.43 | 2.95 | 27,766,360.00 | 6.82 | -- | 8.43 | -- | 55.74 | -- | 14.36 | -- | 2.68 | -- | 0.1105 | -- | 2.81 | -- | 124.87 | -- | -- | -- |
| Immuno-Biological Laboratories Co., Ltd. | 1.03bn | 363.89m | 16.10bn | 58.00 | 44.23 | 9.13 | 59.39 | 15.60 | 39.07 | 39.07 | 110.76 | 189.25 | 0.5456 | 0.8603 | 4.81 | 17,786,030.00 | 19.25 | -4.96 | 22.46 | -5.77 | 70.35 | 62.70 | 35.27 | -11.27 | 3.96 | 2,702.08 | 0.0947 | -- | 18.71 | 10.95 | 33.40 | -- | -- | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.21bn | 17.01bn | 14.00 | -- | 6.55 | -- | -- | -62.53 | -62.53 | 0.00 | 131.71 | 0.00 | -- | -- | 0.00 | -37.50 | -57.04 | -41.74 | -62.13 | -- | -- | -- | -4,587.85 | -- | -- | 0.00 | -- | -- | -- | 4.27 | -- | -- | -- |
| Ohki Healthcare Holdings Co Ltd | 359.41bn | 2.43bn | 18.45bn | 648.00 | 7.35 | 0.5382 | 6.52 | 0.0513 | 178.43 | 178.43 | 26,346.69 | 2,435.83 | 2.26 | 9.83 | 4.34 | 554,637,400.00 | 1.53 | 1.77 | 6.23 | 7.74 | 5.31 | 5.26 | 0.677 | 0.6977 | 0.8306 | -- | 0.2686 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| StemRIM Inc | 0.00 | -1.90bn | 18.55bn | 45.00 | -- | 2.70 | -- | -- | -30.56 | -30.56 | 0.00 | 109.73 | 0.00 | -- | -- | 0.00 | -24.08 | -12.71 | -24.55 | -12.88 | -- | -- | -- | -167.35 | 47.00 | -- | 0.00 | -- | -- | -- | 4.59 | -- | -22.11 | -- |
| Astena Holdings Co Ltd | 62.74bn | 2.19bn | 20.18bn | 1.42k | 9.06 | 0.7313 | 4.38 | 0.3216 | 54.22 | 54.22 | 1,555.72 | 671.41 | 0.8961 | 3.62 | 2.88 | -- | 3.11 | 0.9587 | 6.26 | 1.76 | 34.85 | 30.40 | 3.47 | 1.05 | 0.9228 | -- | 0.4519 | 114.25 | 8.19 | -0.808 | 186.60 | 1.97 | 12.61 | 2.38 |
| Fuso Pharmaceutical Industries Ltd | 62.17bn | -4.86bn | 22.45bn | 1.34k | -- | 0.5851 | -- | 0.3611 | -568.90 | -568.90 | 7,280.21 | 4,059.08 | 0.7307 | 3.25 | -- | 46,394,780.00 | -5.71 | 0.7682 | -12.18 | 1.29 | 26.39 | 26.94 | -7.82 | 1.05 | 0.8228 | 42.56 | 0.4617 | 106.29 | 9.31 | 5.25 | -338.78 | -- | 4.37 | 6.45 |
| Renascience Inc | 86.94m | 34.67m | 23.39bn | 3.00 | 647.19 | 14.30 | 125.43 | 268.98 | 2.73 | 2.73 | 6.84 | 123.38 | 0.0478 | -- | -- | 28,981,330.00 | 1.90 | -8.97 | 2.00 | -9.35 | 95.31 | 84.44 | 39.87 | -107.53 | -- | -- | 0.00 | -- | -31.66 | 13.00 | 143.91 | -- | -- | -- |
| RaQualia Pharma Inc | 3.05bn | -724.12m | 27.11bn | 85.00 | -- | 4.22 | -- | 8.89 | -30.73 | -30.73 | 132.63 | 247.06 | 0.3165 | 4.31 | 6.15 | 35,872,500.00 | -7.52 | 0.1792 | -8.40 | 0.1931 | 74.55 | 86.78 | -23.75 | 0.453 | 4.48 | -13.69 | 0.3354 | 0.00 | 63.45 | 12.78 | -52.95 | -- | 4.19 | -- |
Data as of Feb 13 2026. Currency figures normalised to StemRIM Inc's reporting currency: Japanese Yen JPY
0.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 08 Jan 2026 | 82.10k | 0.13% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 38.70k | 0.06% |
| Schroder Investment Management (Japan) Ltd.as of 25 Apr 2024 | 22.60k | 0.04% |
| Connor, Clark & Lunn Investment Management Ltd.as of 30 Jun 2025 | 1.10k | 0.00% |
| Daiwa Asset Management Co. Ltd.as of 30 Jun 2025 | 500.00 | 0.00% |
| Meiji Yasuda Asset Management Co. Ltd.as of 29 Nov 2024 | 0.00 | 0.00% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 26 Feb 2024 | 0.00 | 0.00% |
| LGT Capital Partners AG (Investment Management)as of 31 May 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 03 Feb 2026Source: FactSet Research Systems Inc.
